ProfileGDS5678 / 1458264_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 57% 50% 50% 50% 49% 54% 52% 50% 49% 50% 50% 50% 51% 50% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.4848757
GSM967853U87-EV human glioblastoma xenograft - Control 23.2062350
GSM967854U87-EV human glioblastoma xenograft - Control 33.209950
GSM967855U87-EV human glioblastoma xenograft - Control 43.1508450
GSM967856U87-EV human glioblastoma xenograft - Control 53.1166449
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.4369154
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.3495952
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1830950
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.1451749
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.1656350
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.1967150
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1756150
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.2254451
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.202650